Business Description
Pharmsville Co Ltd
ISIN : KR7318010006
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 36.55 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.5 | |||||
Interest Coverage | 0.21 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.54 | |||||
Beneish M-Score | -2.85 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -9.6 | |||||
3-Year EBITDA Growth Rate | -18.8 | |||||
3-Year EPS without NRI Growth Rate | -19.3 | |||||
3-Year Book Growth Rate | 4.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 27.49 | |||||
9-Day RSI | 34.52 | |||||
14-Day RSI | 37.18 | |||||
6-1 Month Momentum % | -20.22 | |||||
12-1 Month Momentum % | -35.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.23 | |||||
Quick Ratio | 8.64 | |||||
Cash Ratio | 8.4 | |||||
Days Inventory | 131.66 | |||||
Days Sales Outstanding | 23.95 | |||||
Days Payable | 66.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.85 | |||||
Dividend Payout Ratio | 0.48 | |||||
3-Year Dividend Growth Rate | -20.6 | |||||
Forward Dividend Yield % | 1.85 | |||||
5-Year Yield-on-Cost % | 1.85 | |||||
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | 14.54 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.5 | |||||
Operating Margin % | 0.07 | |||||
Net Margin % | 8.65 | |||||
FCF Margin % | 15.73 | |||||
ROE % | 2.58 | |||||
ROA % | 2.3 | |||||
ROIC % | 0.04 | |||||
ROC (Joel Greenblatt) % | 10.51 | |||||
ROCE % | 2.47 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 25.47 | |||||
PE Ratio without NRI | 25.97 | |||||
Price-to-Owner-Earnings | 38.18 | |||||
PS Ratio | 2.21 | |||||
PB Ratio | 0.66 | |||||
Price-to-Tangible-Book | 0.66 | |||||
Price-to-Free-Cash-Flow | 13.99 | |||||
Price-to-Operating-Cash-Flow | 13.03 | |||||
EV-to-EBIT | 1.19 | |||||
EV-to-EBITDA | 0.88 | |||||
EV-to-Revenue | 0.11 | |||||
EV-to-FCF | 0.68 | |||||
Price-to-Graham-Number | 0.87 | |||||
Price-to-Net-Current-Asset-Value | 1.1 | |||||
Price-to-Net-Cash | 1.23 | |||||
Earnings Yield (Greenblatt) % | 83.84 | |||||
FCF Yield % | 7.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pharmsville Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 19,037.639 | ||
EPS (TTM) (â‚©) | 212 | ||
Beta | 0.07 | ||
Volatility % | 16.31 | ||
14-Day RSI | 37.18 | ||
14-Day ATR (â‚©) | 195.618598 | ||
20-Day SMA (â‚©) | 5705 | ||
12-1 Month Momentum % | -35.91 | ||
52-Week Range (â‚©) | 5310 - 9140 | ||
Shares Outstanding (Mil) | 7.73 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharmsville Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharmsville Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Pharmsville Co Ltd Frequently Asked Questions
What is Pharmsville Co Ltd(XKRX:318010)'s stock price today?
When is next earnings date of Pharmsville Co Ltd(XKRX:318010)?
Does Pharmsville Co Ltd(XKRX:318010) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |